NxStage Medical (NXTM)

15.29 -0.17  -1.10%  May 30, 5:20PM Go Pro
Watch this stock
View Full Chart NXTM Price Chart

Key Stats

Market Cap 852.26M
Revenue Growth 12.63%
Profit Margin -9.03%
Earnings Yield -2.42%
Dividend Yield 0.00%
Earnings Per Share TTM -0.37
PE Ratio
Price / Sales Ratio 3.811
52 Week High 24.06
52 Week Low 14.83
Beta 0.8226
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 24 FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits with More ...
May 24 A Hidden Reason Nxstage Medical's Future Looks Bright Fool
May 21 Excellent Science + Unmet Need Equal Great Returns Fool
May 20 Bottom 5 Healthcare by 14 period RSI: $LIFE $BAX $AET $CI $HSP (S&P 500) $HNT $TEVA $MAKO $NXTM $HRC (non S&P 500) by TheEquitiesRoom
May 17 9 High-Growth Healthcare Stocks With Strong Inventory Trends
May 15 SAC Capital noteworthy #biotech trading in Q1: New stakes in $OPTR $SNTS $SNTA $MDSO $NXTM, added to $ARIA $AMRN $ENDP, sells $GILD by ajunkmailman
May 14 Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant PR Newswire
May 14 Why NxStage put trade may be bullish
May 11 HIGH $PUT VOLU $NXTM 30364% $GPC 2959% $ALR 2721% $TSM 2477% $WMB 2364% $GSVC 1710% $CQB 1656% $MDR 1619% $FRAN 1576% $WFR 1508% by livevol_pro
May 11 HIGH $PUT VOLU $NXTM 30364% $ALR 2643% $TSM 2463% $CQB 1656% $GSVC 1619% $MDR 1497% $WFR 1410% $CA 865% $ARNA 820% $SVM 812% by livevol_pro
May 08 $NXTM posts double-digit top-line increase and narrows Q1 losses but closes down > 3%, possibly due to a debt-to-equity swap by Asahi Kasei. by abubnic

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Medical Appliances & Equipment

NxStage Medical, Inc. is a medical device company, which develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The company's principal product NxStage System One delivers hemodialysis, hemofiltration, and ultra filtration to patients with renal failure or fluid overload. It operates through two segments: System One and In-Center. NxStage Medical, Inc. offers its products primarily to dialysis clinics, nephrologists, and hospitals that treat acute kidney failure and fluid overload through distributors and sales representatives. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NxStage Medical is down 17.73% over the last year vs S&P 500 Total Return up 2.32%, Cyberonics up 19.57%, and Given Imaging down 24.57%.

  • NXTM Total Returns
  • ^SPXTR Total Returns
  • CYBX Total Returns
  • GIVN Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring NXTM

Did NxStage Medical make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

NXTM Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
NXTM 15.29 -0.17 -1.10% 861.74M
NXST 6.78 -0.05 -0.73% 196.70M
NXQ 14.04 +0.15 +1.08%
NXPI 21.54 -0.71 -3.19% 5.601B
NXP 15.24 +0.08 +0.53%
NXN 14.49 +0.01 +0.07%
NX 16.54 -0.77 -4.45% 636.32M
NWY 3.54 +0.00 +0.00% 219.23M
NTES 61.40 +0.71 +1.17% 7.948B
NTE 4.92 -0.19 -3.72% 228.93M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close